Advisor
CurrentNanOlogy is a privately held, clinical stage oncology company developing novel therapies for the treatment of solid tumors. The Company's patented large surface area microparticle (LSAM) oncology drug platform promises to enhance the efficacy of tumor-directed therapy while minimizing the serious adverse effects associated with systemic cancer treatments.